Publication:
Benefits of prophylactic emicizumab in enhancing immune tolerance induction in a boy with hemophilia A and very high inhibitor titer

Issued Date

2021-09-01

Resource Type

Letter

ISSN

15455017
15455009

DOI

10.1002/pbc.29111

Other identifier(s)

2-s2.0-85105949183

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Pediatric Blood and Cancer. Vol.68, No.9 (2021)

Suggested Citation

Nongnuch Sirachainan, Ampaiwan Chuansumrit, Surapan Parapakpenjune, Pakawan Wongwerawattanakoon, Surapong Lertthammakiat, Praguywan Kadegasem, Werasak Sasanakul Benefits of prophylactic emicizumab in enhancing immune tolerance induction in a boy with hemophilia A and very high inhibitor titer. Pediatric Blood and Cancer. Vol.68, No.9 (2021). doi:10.1002/pbc.29111 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/77926

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

Benefits of prophylactic emicizumab in enhancing immune tolerance induction in a boy with hemophilia A and very high inhibitor titer

Author(s)

Nongnuch Sirachainan
 Ampaiwan Chuansumrit
 Surapan Parapakpenjune
 Pakawan Wongwerawattanakoon
 Surapong Lertthammakiat
 Praguywan Kadegasem
 Werasak Sasanakul

Other Contributor(s)

Faculty of Medicine Ramathibodi Hospital, Mahidol University
 Maharaj Nakhon Ratchasima Hospital

Keyword(s)

Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/20.500.14594/77926

Collections

Scopus 2021